The Centers for Disease Control and Prevention (CDC) are currently soliciting written comments on pain and pain management, including those relevant to the benefits and harms of opioid use, to help inform the agency’s understanding of the subject from the varied perspectives and experiences of their stakeholders.
These stakeholders encompass patients with acute or chronic pain, patients’ family members and/or caregivers, and health care providers who care for patients with pain or conditions that can complicate pain management such as opioid use disorder or overdose.
All written submissions received need to include the agency name and Docket Number: CDC-2020-0029. The deadline to submit is June 16, 2020.
Comments can be submitted in one of two ways:
Visit the Federal eRulemaking Portal and follow the instructions for submitting comments.
OR
Mail your comments to:
Centers for Disease Control and Prevention
1600 Clifton Road NE, Mailstop S106-9
Atlanta, Georgia 30329
An important note: Comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential, proprietary, or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display.
Source: Painweek.org, April 20, 2020
